Research suggests that the gut microbiota plays a role in shaping responses to cancer immunotherapy. The relationship between the gut microbiome and cancer immune response is complex, with some studies indicating that it can influence the efficacy of immunotherapy, while others highlight its potential as a modulator of drug sensitivity. The gut microbiome's impact on cancer treatment response is being explored in various contexts, including its potential interaction with certain drugs and its role in specific types of cancer.